Article
PRMT3-mediated arginine methylation of YBX1 promotes tumorigenesis in glioblastoma
2026-02-27
Abstract excerpt
<title>Abstract</title> <p> Glioblastoma (GBM) represents one of the most challenging tumor types to treat clinically, characterized by an exceedingly poor patient prognosis. This is primarily attributable to the ambiguous molecular mechanisms that hinder the advancement of targeted therapies. Here, PRMT3 is identified as a key driver of tumorigenesis in GBM. Bioinformatics and clinical data reveal that high exp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8b6d55c0-a457-5689-b1d9-d07f62ffe87a
- DOI
- 10.21203/rs.3.rs-8924648/v1
